General Atlantic-backed Centessa opens marginally above IPO price

Centessa Pharmaceuticals

28/05/2021 17:00

** American Depositary Shares (ADS) of biopharma co Centessa
Pharmaceuticals  CNTA.O  open ~1.3% above their IPO price in
market debut
    ** Centessa, backed by private equity firm General Atlantic,
was valued at $1.74 bln at debut; VC firm Index Ventures and
life sciences-focused investment firm Medicxi are among CNTA's
other backers  urn:newsml:reuters.com:*:nL3N2NB387
    ** Stock opened at $20.25/ADS, marginally up from IPO price
of $20/ADS
    ** On Thursday, co priced its upsized offering of 16.5 mln
ADS to raise about $330 mln  urn:newsml:reuters.com:*:nBwc4wCFa
    ** Each ADS represents one ordinary share
    ** CNTA plans to locate its headquarters in Cambridge,
Massachusetts, it said in its initial filing last month
    ** Morgan Stanley, Goldman Sachs & Co, Jefferies and
Evercore ISI were the underwriters for the IPO

 (Reporting by Niket Nishant in Bengaluru)
 ((Niket.Nishant@thomsonreuters.com))